drugset
drugset / Trial / NCT00566254

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

NCT00566254 ↗

Phase 3 Completed 207 enrolled Eisai Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the safety and efficacy of zonisamide with placebo.

Timeline

Start
2008-12
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Zonisamide Other / unclassified 8 mg/kg —

Indications

simple partial epilepsy